Population
Myogenic cell lines and a cosmid clone containing the first exon of the Duchenne muscular dystrophy (DMD) gene
Design
Preclinical
Authors
Loading...
Does not alter DMD management; extends promoter mapping for future muscle-targeted gene therapy vectors.
Identifies the minimal promoter region (149 bp) and key regulatory elements required for muscle-specific transcription of the Duchenne muscular dystrophy gene.
Klamut et al. (1990) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: